Vera Therapeutics, Inc. - Class A Common Stock (NQ:VERA)

30.42 -0.57 (-1.84%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vera Therapeutics, Inc. - Class A Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 15, 2023

Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 14, 2023

Via Benzinga

Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

June 12, 2023

Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord.

Via Benzinga

Why Shares of Vera Therapeutics Are Soaring Monday ↗

June 12, 2023

The company, which specializes in autoimmune disorders affecting the kidney, benefited from a renewed interest in kidney therapies.

Via The Motley Fool

US Stocks Open Higher; Nasdaq Rises Over 50 Points ↗

June 12, 2023

U.S. stocks traded higher this morning, with Nasdaq Composite gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.21% to 33,948.78 while the NASDAQ rose 0.47% to...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 12, 2023

Via Benzinga

7 Stocks That Wall Street Analysts Are Loving in June ↗

June 11, 2023

Sometimes, it’s better to get your ideas from the experts. Thus, if you lack time, these top analyst recommend stocks could be enticing.

Via InvestorPlace

Vera Therapeutics to Participate in the 44th Annual Goldman Sachs Global Healthcare Conference

June 08, 2023

From Vera Therapeutics

Via GlobeNewswire

Recap: Vera Therapeutics Q1 Earnings ↗

May 11, 2023

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Vera Therapeutics: Here's What You Need To Know ↗

March 29, 2023

Via Benzinga

Vera Therapeutics Initiates Pivotal Phase 3 (ORIGIN 3) Clinical Trial of Atacicept for the Treatment of IgA Nephropathy (IgAN)

June 07, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Provides Business Update and Reports First Quarter Financial Results

May 11, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Appoints Kerry Cooper, M.D., as Senior Vice President of Medical Affairs

May 04, 2023

From Vera Therapeutics

Via GlobeNewswire

Why Vera Therapeutics Stock Bolted Higher This Week ↗

January 22, 2023

Vera's stock gained a noteworthy 49% this week.

Via The Motley Fool

$12M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying ↗

April 04, 2023

Although US stocks closed mixed on Monday, there were a few notable insider trades.

Via Benzinga

Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results

March 28, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics to Participate in the Cowen 43rd Annual Health Care Conference

February 27, 2023

From Vera Therapeutics

Via GlobeNewswire

$12M Bet On Vera Therapeutics? Check Out These 3 Stocks Insiders Are Buying ↗

February 09, 2023

Although US stocks closed lower on Wednesday, there were a few notable insider trades.

Via Benzinga

Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock

February 06, 2023

From Vera Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

February 02, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

February 02, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

Via InvestorPlace

Vera Therapeutics Announces Pricing of Public Offering of Class A Common Stock

February 01, 2023

From Vera Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

February 01, 2023

Via Benzinga

Vera Therapeutics Announces Commencement of Public Offering of Class A Common Stock

February 01, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Releases Interim Analysis Of Rare Kidney Disease Drug, Deprioritizes Certain Phase 3 Programs ↗

January 30, 2023

Vera Therapeutics Inc (NASDAQ: VERA) has announced results from a prespecified per-protocol (PP) analysis of the Phase 2b ORIGIN trial of atacicept in IgA nephropathy (IgAN) patients.

Via Benzinga

Vera Therapeutics Releases 36 Week Interim Analysis of Phase 2b Clinical Trial of Atacicept for the Treatment of IgA Nephropathy; Patients in the 150 mg Dose Group Achieved a Delta of 48% Versus Placebo in Mean Reduction in Proteinuria

January 30, 2023

From Vera Therapeutics

Via GlobeNewswire

Vera Therapeutics Hosting a Key Opinion Leader Webinar on Atacicept for the Treatment IgA Nephropathy (IgAN)

January 25, 2023

From Vera Therapeutics

Via GlobeNewswire

5 Cheapest Health Care Stocks You Should Think About ↗

January 13, 2023

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Vera Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm

January 12, 2023

From The Schall Law Firm

Via Business Wire

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.